Leveraging adenosine triphosphate for cancer theranostics
Theranostics · 2025
DOI: 10.7150/thno.106291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2025. Verfasst von Yuhan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Neoplasms, Adenosine Triphosphate, Theranostic Nanomedicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zitieren
APA
Li, Y., Zhang, X., Wang, J., Wang, K., Li, B., Qiao, X., He, W., Cai, J., Liu, D., & Yang, L. L. (2025). Leveraging adenosine triphosphate for cancer theranostics. Theranostics. https://doi.org/10.7150/thno.106291
Vancouver
Li Y, Zhang X, Wang J, Wang K, Li B, Qiao X, et al. Leveraging adenosine triphosphate for cancer theranostics. Theranostics. 2025. doi:10.7150/thno.106291
BibTeX
@article{Li2025,
author = {Li, Yuhan and Zhang, Xinyu and Wang, Jianhua and Wang, Kexin and Li, Boya and Qiao, Xianghe and He, Wei and Cai, Jinghua and Liu, Danfeng and Yang, Lei-Lei},
title = {Leveraging adenosine triphosphate for cancer theranostics},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.106291}
}
EUVIMED